Whalegun
Lobbying

CMC Pharmaceuticals's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $120K. Its first report covers Q2 2023; the issues it reports most are Budget/Appropriations and Defense.

CMC Pharmaceuticals

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$120K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q2 2023
The first quarter a report named it

Lobbying by quarter

CMC Pharmaceuticals lobbying by quarter
CMC Pharmaceuticals lobbying by quarter
QuarterAmountReports
Q2 2023$20K1
Q3 2023$10K1
Q4 2023$40K1
Q1 2024$40K1
Q2 2024$40K1
Q3 2024$40K1
Q4 2024$40K1
Q1 2025$40K1
Q2 2025$40K1
Q3 2025$40K1
Q4 2025$40K1
Q1 2026$40K1
Q2 2026$40K1
Q3 2026$00

By issue

  • Budget and appropriations$156.7K · 13 reports
  • Defense$156.7K · 13 reports
  • Government issues$156.7K · 13 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Defense, Dept of (DOD)13 reports
  • HOUSE OF REPRESENTATIVES13 reports
  • SENATE13 reports
  • White House Office13 reports

Firms it paid

Firm
Capitol Counsel$470K13 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/17for Q2Capitol Counsel$40K
04/20for Q1Capitol Counsel$40K
01/19for Q4 2025Capitol Counsel$40K
25/10/18for Q3 2025Capitol Counsel$40K
25/07/21for Q2 2025Capitol Counsel$40K
25/04/19for Q1 2025Capitol Counsel$40K
25/01/14for Q4 2024Capitol Counsel$40K
24/10/17for Q3 2024Capitol Counsel$40K
24/07/18for Q2 2024Capitol Counsel$40K
24/04/21for Q1 2024Capitol Counsel$40K
24/01/21for Q4 2023Capitol Counsel$40K
23/10/17for Q3 2023Capitol Counsel$10K
23/07/20for Q2 2023Capitol Counsel$20K
23/07/18for Q2 2023Capitol CounselUnder $5,000